Literature DB >> 23095406

Sensors and hybrid therapies: a new approach with automated citrate anticoagulation.

Balazs Szamosfalvi1, Stanley Frinak, Jerry Yee.   

Abstract

BACKGROUND: Hybrid therapies use intermittent hemodialysis (IHD) machines adapted to provide prolonged intermittent or continuous renal replacement therapy in the intensive care unit (ICU). Despite the low cost, hybrid therapy use is limited warranting a novel approach.
METHODS: The literature was reviewed for limitations of hybrid protocols, use of regional citrate anticoagulation (RCA) on hybrid systems and sensors for IHD and hybrid therapy. The novel hybrid program in the authors' institution is presented as a plausible future direction for the modality.
RESULTS: Hybrid therapies are limited by access flow and clotting alarms. Technology limitations render many IHD sensors inoperable at low dialysate flow. A synergy with RCA allows a novel, safe approach with low blood flows and high dialysate flows with alarm- and clotting-free operation and all commercial IHD sensors functional.
CONCLUSION: The low cost, ease of use, safety and efficacy of hybrid therapy with near-automated RCA may lead to rapid expansion of this form of ICU renal support.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23095406     DOI: 10.1159/000341644

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  4 in total

1.  Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment.

Authors:  Enrico Fiaccadori; Giuseppe Regolisti; Carola Cademartiri; Aderville Cabassi; Edoardo Picetti; Maria Barbagallo; Tiziano Gherli; Giuseppe Castellano; Santo Morabito; Umberto Maggiore
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

2.  Anticoagulation strategies in continuous kidney replacement therapy - does one size fit all?

Authors:  Akash Deep
Journal:  Pediatr Nephrol       Date:  2022-05-18       Impact factor: 3.651

3.  Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement.

Authors:  Marcus Broman; Bengt Klarin; Karin Sandin; Ola Carlsson; Anders Wieslander; Jan Sternby; Gabriela Godaly
Journal:  ASAIO J       Date:  2015 Jul-Aug       Impact factor: 2.872

Review 4.  The future of critical care: renal support in 2027.

Authors:  William R Clark; Mauro Neri; Francesco Garzotto; Zaccaria Ricci; Stuart L Goldstein; Xiaoqiang Ding; Jiarui Xu; Claudio Ronco
Journal:  Crit Care       Date:  2017-04-11       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.